نتایج جستجو برای: neuroprotective agents

تعداد نتایج: 375266  

Journal: :مجله علوم اعصاب شفای خاتم 0
elham mohammadzadeh a. shefa neuroscience research, khatam alanbia hospital, tehran, iran b. department of biology and anatomical sciences, faculty of medicine, shahid beheshti university of medical sciences, tehran, iran sajad sahab negah a. shefa neuroscience research, khatam alanbia hospital, tehran, iran b. histology and embryology group, basic science department, faculty of veterinary medicine, shiraz university, shiraz, iran arezou eshaghabadi shefa neuroscience research, khatam alanbia hospital, tehran, iran

traumatic brain injury (tbi) is one of the leading causes of death in men under the age of 35 that mostly occurs due to the road accidents. current clinical treatments have not enough repair and prevention of secondary damage caused by cytotoxicity. progesterone, as a primary sex hormone, acts as neuroprotection in tbi and stroke. progesterone increases anti-oxidants and decreases inflammation ...

Journal: :Brain research 2011
Gong-Jhe Wu Wu-Fu Chen Han-Chun Hung Yen-Hsuan Jean Chun-Sung Sung Chiranjib Chakraborty Hsin-Pai Lee Nan-Fu Chen Zhi-Hong Wen

Recently, it has been suggested that anesthetic agents may have neuroprotective potency. The notion that anesthetic agents can offer neuroprotection remains controversial. Propofol, which is a short-acting intravenous anesthetic agent, may have potential as a neuroprotective agent. In this study, we tried to determine whether propofol affected the viability of human neuroblastoma SH-SY5Y cells ...

A Forozan A.R Azizzadeh delshad

Background & Aims: Since apoptotic cell death plays a crucial role in many neurodegenerative diseases, control of apoptosis can be taken into account as a putative neuroprotective strategy. Due to the reported neuroprotective effect of the herbal medicine Nepeta Menthoides (Ostokhodus) on the axotomy-induced apoptosis in the spinal motoneurons, in the present study we have investigated its prop...

Journal: :Stroke 2004
Helmi L Lutsep

Strokes still cause death every 3.3 minutes in the United States and are a leading cause of disability. Although the thrombolytic tissue plasminogen activator has been available for the treatment of ischemic stroke since 1996, no neuroprotectant acute stroke treatment strategy to preserve dysfunctional neurons in the ischemic penumbra has shown efficacy in clinical trials. New approaches for th...

Journal: :Stroke 1999
G Sulter C Steen J De Keyser

BACKGROUND AND PURPOSE The Barthel Index (BI) and the Modified Rankin Scale (MRS) are commonly used scales that measure disability or dependence in activities of daily living in stroke victims. The objective of this study was to investigate how these scales were used and interpreted in acute stroke trials. METHODS We identified from MEDLINE the major efficacy trials with neuroprotective drugs...

2016
Vincenzo Parisi Lucia Ziccardi Gloria Roberti Lucia Tanga Gianluca Manni

Oral form of citicoline, a nootropic and neuroprotective drug in use for almost five decades, recently was pronounced a food supplement in both USA and EU. The idea of adding citicoline to topical treatment of primary open angle glaucoma (POAG) aimed at decreasing intraocular pressure (IOP) appeared as a logical consequence of accepting neurodegenerative character of this disease. Experimental ...

2013
Stacey E. Seidl Judith A. Potashkin

Received: 27 March 2013; accepted: 15 April 2013; published online: 01 May 2013. Citation: Seidl SE and Potashkin JA (2013) Erratum: The promise of neuroprotective agents in Parkinson’s disease. Front. Neurosci. 7:69. doi: 10.3389/fnins. 2013.00069 This article was submitted to Frontiers in Neuropharmacology, a specialty of Frontiers in Neuroscience. Copyright © 2013 Seidl and Potashkin. This i...

2008
R. Holly Christine P. Brown Glenn D. Rosen

Neonatally induced microgyric lesions produce defects in rapid auditory processing in adult male rats. Given that females across species are less susceptible to the deleterious effects of neural injury and that treatment with neuroprotective agents at the time of injury can reduce neural damage, the authors tested the effects of sex and neuroprotectant exposure on the behavioral consequences of...

2010
Pierre-Olivier Fernagut Qin Li Sandra Dovero Piu Chan Tao Wu Paula Ravenscroft Michael Hill Zhenwen Chen Erwan Bezard

BACKGROUND Radiotracer imaging of the presynaptic nigrostriatal dopaminergic system is used to assess disease progression in Parkinson's disease (PD) and may provide a useful adjunct to clinical assessment during therapeutic trials of potential neuroprotective agents. Several clinical trials comparing dopamine agonists to L-DOPA or early vs. late L-DOPA have revealed differences between clinica...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید